News

The best approach for atrial fibrillation is not the either-or of catheter ablation vs risk management, but a combination of ...
Boston Scientific raised its annual profit forecast on Wednesday, banking on strong demand for its heart devices, and trimmed ...
His new clinic, Emerald Coast Heart & AFib, is committed to providing individualized, evidence-based treatments such as catheter ablation, Watchman left ... when managing chronic conditions like ...
Havasu Regional Medical Center has reached another milestone, having completed its 100th ablation procedure for atrial ...
Revenue rose 22.8 % to $5.06 billion, beating expectations and guidance.- Adjusted EPS reached $0.75, surpassing analyst ...
Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...
Brent Gardner of Rigby is sure that he was a couple of weeks away from death when he received the first TriClip transcatheter ...
The company now expects a tariff charge of $100 million this year, down from a $200 million impact forecast on the company’s ...
For a moment, it appeared Boston Scientific was having a rare bumpy quarter. Executives in April had estimated tariffs would ...
Boston Scientific raised its annual profit forecast, after strong demand for its heart devices helped the U.S. medical device ...
A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons, finds that Medicare ...
The medical device manufacturer expects 2025 adjusted profit of $2.95 to $2.99 per share, up from the prior view of $2.87 to ...